Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatic Impairment”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Early research (Phase 1)Study completedNCT01919125
What this trial is testing

Pharmacokinetics of IDX719 in Participants With Normal and Impaired Hepatic Function (MK-1894-008)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 36
Not applicableStudy completedNCT00305591
What this trial is testing

Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment.

Who this might be right for
CirrhosisHepatic Encephalopathy
Imperial College London 50
Early research (Phase 1)Study completedNCT00759837
What this trial is testing

Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects

Who this might be right for
Breast CancerLeukemia, Myeloid, Chronic
Wyeth is now a wholly owned subsidiary of Pfizer 27
Early research (Phase 1)Study completedNCT01790607
What this trial is testing

An Open-label, Single-dose, Intravenous Administration Study of ONO-2745/CNS 7056 in Subjects With Chronic Hepatic Impairment

Who this might be right for
Hepatic ImpairmentHealthy
Ono Pharma USA Inc 20
Not applicableStudy completedNCT00424957
What this trial is testing

Brain Energy Metabolism in Patients With Chronic Liver Disease and Impaired Central Nervous System

Who this might be right for
CirrhosisHepatic Encephalopathy
University of Aarhus 18
Early research (Phase 1)Study completedNCT00781430
What this trial is testing

Study Evaluating The PK And Safety Of Neratinib In Healthy Subjects And Subjects With Chronic Liver Disease

Who this might be right for
Hepatic Insufficiency
Puma Biotechnology, Inc. 27
Testing effectiveness (Phase 2)Study completedNCT01830127
What this trial is testing

BI 207127 / Faldaprevir Combination Therapy in Hepatic Impairment (Child-Pugh B) Patients With Genotype 1b Chronic Hepatitis C Infection: HCVerso3

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 35
Early research (Phase 1)Study completedNCT04454424
What this trial is testing

Study on the Safety of BAY1817080, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug in Participants With Impaired Liver Function or Normal Liver Function

Who this might be right for
Endometriosis Related PainOveractive BladderDiabetic Neuropathic Pain+1 more
Bayer 37
Post-approval studies (Phase 4)Study completedNCT01846455
What this trial is testing

Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects

Who this might be right for
Hepatic FailureHepatic ImpairmentChronic Hepatitis C Infection With Hepatic Coma
Indivior Inc. 43
Early research (Phase 1)Study completedNCT03814005
What this trial is testing

Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute+3 more
Takeda 17
Early research (Phase 1)Not Yet RecruitingNCT07394309
What this trial is testing

Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls

Who this might be right for
Liver Fibrosis
Beijing Continent Pharmaceutical Co, Ltd. 30
Early research (Phase 1)Study completedNCT05624710
What this trial is testing

Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

Who this might be right for
Renal InsufficiencyKidney Diseases
Incyte Corporation 25
Early research (Phase 1)Study completedNCT01497327
What this trial is testing

Open-Label Hepatic Impairment Study

Who this might be right for
Hepatitis C
Gilead Sciences 24
Early research (Phase 1)Study completedNCT00314054
What this trial is testing

Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults

Who this might be right for
Hepatitis CHepatic Insufficiency
Wyeth is now a wholly owned subsidiary of Pfizer 27
Early research (Phase 1)Study completedNCT04881994
What this trial is testing

Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult Participants With Different Degrees of Reduced Liver Function and in Healthy Participants With Similar Age, Weight and Gender Distribution

Who this might be right for
Worsening Chronic Heart FailureDiabetic Nephropathy
Bayer 27
Early research (Phase 1)Study completedNCT01577680
What this trial is testing

Assess the Effects of GSK573719/VI Combination and GSK573719 Monotherapy in Subjects With Moderate Hepatic Impairment and Matched Healthy Volunteers

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 18
Early research (Phase 1)Study completedNCT06402721
What this trial is testing

Learn About How BAY 3283142 Moves Into, Through, and Out of the Body After a Single Dose in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function

Who this might be right for
Chronic Kidney DiseaseHepatic Impairment
Bayer 24
Early research (Phase 1)Study completedNCT01465412
What this trial is testing

Assess Pharmacokinetics of Preladenant in Participants With Chronic Hepatic Impairment (P06513)

Who this might be right for
Chronic Hepatic Impairment
Merck Sharp & Dohme LLC 42
Early research (Phase 1)Study completedNCT02095587
What this trial is testing

Duvelisib in Hepatically Impaired Subjects Compared to Healthy Subjects

Who this might be right for
Hepatic Impairment
SecuraBio 24
Early research (Phase 1)Study completedNCT06736223
What this trial is testing

Pharmacokinetics, Safety and Tolerability of ITF2357 in Participants With Chronic Hepatic Impairment and With Normal Hepatic Function

Who this might be right for
Hepatic Impairment
Italfarmaco 24
Load More Results